| | | | | |
PYXS Pyxis Oncology, Inc. Common Stock | €2,9943 | +7,79% | €231,70M | €476,68K | |
AIFU AIFU Inc. Class A Ordinary Share | €9,4285 | +1,44% | €231,42M | €37,39K | |
PMO Franklin Municipal Opportunities Trust | €8,3823 | -0,76% | €231,42M | €24,17K | |
VABK Virginia National Bankshares Corporation Common Stock | €42,2108 | -0,90% | €231,08M | €4,62K | |
CAMP CAMP4 Therapeutics Corporation Common Stock | €3,7273 | +1,34% | €230,80M | €103,86K | |
| €12,2852 | +0,04% | €230,78M | €28,55K | |
| €8,1850 | +8,09% | €230,53M | €199,50K | |
DSP Viant Technology Inc. Class A Common Stock | €11,1117 | +2,07% | €230,09M | €136,77K | |
EGHT 8x8, Inc. Common Stock | €1,5967 | +0,27% | €229,98M | €888,82K | |
| €17,2180 | -4,02% | €229,65M | €70,72K | |
RILY BRC Group Holdings, Inc. Common Stock | €5,3655 | -6,06% | €229,60M | €489,87K | |
MIN Aberdeen Intermediate Income Fund | €2,0207 | +0,22% | €229,46M | €232,89K | |
TRDA Entrada Therapeutics, Inc. Common Stock | €5,9713 | +1,47% | €229,13M | €135,02K | |
| €3,6572 | +3,83% | €228,65M | €138,79K | |
OACC Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share | €9,3264 | +0,11% | €228,48M | €4,16K | |
